Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
KINETA, INC./DE (KA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
20 Sep 2023
PHILIPS CRAIG W.
President, Officer
KINETA, INC./DE
(KA)
57,811
+6%
3,500
$2.43
$8,494.59
BUY
20 Sep 2023
Kenny Pauline
General Counsel & Secretary, Officer
KINETA, INC./DE
(KA)
18,448
+8%
1,500
$2.58
$3,870.00
BUY
20 Sep 2023
Iadonato Shawn
Chief Executive Officer, Director, Officer
KINETA, INC./DE
(KA)
670,230
+1%
10,000
$2.50
$25,042.00
BUY
19 Sep 2023
Bartoszek Raymond J.
Director
KINETA, INC./DE
(KA)
14,956
+15%
2,000
$2.37
$4,745.00
BUY
18 Sep 2023
Baker Keith
Chief Financial Officer, Officer
KINETA, INC./DE
(KA)
16,880
+42%
5,000
$2.13
$10,672.50
BUY
15 Sep 2023
Bartoszek Raymond J.
Director
KINETA, INC./DE
(KA)
12,956
+30%
3,000
$2.10
$6,290.00
BUY
14 Sep 2023
Guillaudeux Thierry
Chief Scientific Officer, Officer
KINETA, INC./DE
(KA)
21,696
+85%
10,000
$2.00
$20,000.00
BUY
16 Jun 2023
Baker Keith
Chief Financial Officer, Officer
KINETA, INC./DE
(KA)
11,880
+72%
5,000
$2.92
$14,600.00
SELL
17 Mar 2023
Iadonato Shawn
Chief Executive Officer, Director, Officer
KINETA, INC./DE
(KA)
666,287
-0%
2,699
$4.26
$11,486.02
SELL
17 Mar 2023
PHILIPS CRAIG W.
President, Officer
KINETA, INC./DE
(KA)
66,977
-3%
2,103
$4.26
$8,951.66
SELL
17 Mar 2023
Kenny Pauline
General Counsel & Secretary, Officer
KINETA, INC./DE
(KA)
17,806
-6%
1,311
$4.26
$5,580.44
BUY
30 Dec 2022
Bartoszek Raymond J.
Director
KINETA, INC./DE
(KA)
9,956
+236%
7,001
$6.23
$43,581.23
SELL
2 Dec 2022
Epstein Marie
Principal Accounting Officer, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
8,883
-18%
1,976
$1.69
$3,341.42
SELL
2 Dec 2022
Smith Devin Whittemore
SVP and General Counsel, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
13,961
-18%
3,116
$1.69
$5,269.16
SELL
2 Dec 2022
Peters Richard
President and CEO, Director, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
90,028
-10%
10,890
$1.69
$18,418.26
SELL
2 Dec 2022
Wyzga Michael D
See Remarks, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
13,997
-18%
3,116
$1.69
$5,270.09
SELL
5 Jul 2022
Peters Richard
President and CEO, Director, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
100,918
-4%
4,584
$1.85
$8,476.27
SELL
3 Jun 2022
Epstein Marie
Principal Accounting Officer, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
10,859
-14%
1,806
$1.19
$2,157.45
SELL
3 Jun 2022
Smith Devin Whittemore
SVP and General Counsel, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
17,077
-14%
2,923
$1.19
$3,491.82
SELL
3 Jun 2022
Wyzga Michael D
See Remarks, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
17,113
-14%
2,887
$1.19
$3,448.81
SELL
3 Jun 2022
Peters Richard
President and CEO, Director, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
105,502
-8%
10,206
$1.19
$12,192.09
SELL
28 Mar 2022
Peters Richard
President and CEO, Director, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
115,708
-8%
10,715
$1.85
$19,774.53
SELL
3 Feb 2022
Mohsen Paulash
Chief Business Officer, Officer
YUMANITY THERAPEUTICS, INC.
(YMTX)
59,135
-3%
1,958
$1.83
$3,583.14
SELL
26 Nov 2019
New Enterprise Associates 12, Limited Partnership
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
4,270,691
-1%
64,195.95
$50.30
$3,228,873.20
SELL
1 Feb 2019
Lee Po Shun
See Remarks, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
18,427
-2%
496.55
$59.81
$29,699.65
SELL
1 Feb 2019
Chhabra Meenu
President and CEO, Director, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
80,615
-1%
823.9
$59.84
$49,305.47
SELL
1 Feb 2019
Munoz Benito
Chief Scientific Officer, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
15,439
-2%
475.7
$59.81
$28,453.52
SELL
1 Feb 2019
Gilmartin Geoffrey S.
Chief Development Officer, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
14,911
-2%
459.45
$59.81
$27,479.71
SELL
28 Jan 2019
Lee Po Shun
See Remarks, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
2,312
-4%
115.6
$60.00
$6,936.00
BUY
26 Oct 2018
BERGER FRANKLIN M
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
40,000
+5%
2,000
$135.00
$270,000.00
BUY
18 Dec 2017
Chhabra Meenu
President and CEO, Director, Officer
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
50,218
+4%
2,000
$100.00
$200,000.00
BUY
18 Dec 2017
New Enterprise Associates 12, Limited Partnership
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
5,554,610
+1%
100,000
$100.00
$10,000,000.00
BUY
18 Dec 2017
BARRETT M JAMES
Director, 10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
5,554,610
+1%
100,000
$100.00
$10,000,000.00
BUY
18 Dec 2017
Kelly Jeffery W.
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
102,411
+0%
200
$100.00
$20,000.00
BUY
18 Dec 2017
BERGER FRANKLIN M
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
266,162
+1%
3,000
$100.00
$300,000.00
BUY
14 Dec 2017
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,300,000
+0%
25,201.35
$97.66
$2,461,163.80
SELL
13 Mar 2017
FMR LLC
See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
243,508
-0%
1,250
$258.80
$323,500.00
SELL
10 Mar 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
268,508
-0%
1,250
$240.80
$301,000.00
SELL
8 Mar 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
295,308
-0%
1,465
$241.54
$353,857.00
SELL
6 Mar 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
327,705
-0%
3,000
$260.24
$780,705.25
SELL
2 Mar 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
382,808
-0%
2,250
$278.14
$625,825.00
SELL
28 Feb 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
427,808
-0%
2,250
$292.47
$658,050.00
SELL
24 Feb 2017
FMR LLC
10% Owner, See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
472,808
-0%
1,400
$292.07
$408,900.00
BUY
15 Dec 2016
BERGER FRANKLIN M
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
206,162
+0%
2,000
$223.48
$446,967.22
BUY
12 Dec 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,804,027
+0%
6,065.05
$216.47
$1,312,905.20
BUY
7 Dec 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,682,726
+0%
2,220.85
$216.67
$481,188.72
BUY
2 Dec 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,638,309
+0%
4,398.65
$212.37
$934,122.60
BUY
29 Nov 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,550,336
+0%
8,519.55
$204.72
$1,744,115.90
BUY
21 Nov 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,379,745
+0%
18,093.15
$227.98
$4,124,944.50
BUY
9 Nov 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,018,082
+0%
12,975
$221.02
$2,867,699.50
BUY
3 Nov 2016
Cormorant Asset Management, LLC
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
2,758,582
+0%
16,398.85
$169.05
$2,772,280.00
BUY
14 Sep 2016
New Enterprise Associates 12, Limited Partnership
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,554,610
+0%
23,076.9
$260.00
$5,999,994.00
BUY
14 Sep 2016
BARRETT M JAMES
Director, 10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,554,610
+0%
23,076.9
$260.00
$5,999,994.00
BUY
14 Sep 2016
BERGER FRANKLIN M
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
166,162
+2%
3,461.5
$260.00
$899,990.00
BUY
17 Feb 2016
New Enterprise Associates 12, Limited Partnership
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,093,072
+1%
45,016.2
$160.00
$7,202,592.00
BUY
17 Feb 2016
FMR LLC
See Remark 1
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
1,877,812
+1%
18,750
$160.00
$3,000,000.00
BUY
17 Feb 2016
BARRETT M JAMES
Director, 10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
3,093,072
+1%
45,016.2
$160.00
$7,202,592.00
BUY
17 Feb 2016
Novartis Bioventures Ltd
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
1,873,791
+1%
18,750
$160.00
$3,000,000.00
BUY
17 Feb 2016
BERGER FRANKLIN M
Director
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
96,932
+1%
1,250
$160.00
$200,000.00
BUY
17 Feb 2016
Mirabelli Christopher
Director, 10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
2,149,295
+0%
18,750
$160.00
$3,000,000.00
BUY
10 Feb 2016
PERRIGO Co plc
10% Owner
PROTEOSTASIS THERAPEUTICS, INC.
(PTI)
2,908,067
+0%
6,250
$160.00
$1,000,000.00
Home